Literature DB >> 11595144

Morphological and functional retinal impairment in Alzheimer's disease patients.

V Parisi1, R Restuccia, F Fattapposta, C Mina, M G Bucci, F Pierelli.   

Abstract

OBJECTIVE: Our study aims to assess the optic nerve fiber layer thickness in vivo, the function of the innermost retinal layer and whether a correlation exists between morphological and functional parameters in patients affected by Alzheimer's Disease (AD).
METHODS: Seventeen AD patients (mean age 70.37+/-6.1 years, best corrected visual acuity >8/10 with refractive error between +/-3 sf, intra-ocular pressure (IOP)<18 mmHg) were enrolled. They were compared to 14 age-matched controls. Nerve fiber layer (NFL) thickness was measured by optical coherence tomography (OCT). Three different measurements in each quadrant (superior, inferior, nasal, and temporal) were taken and averaged. The data in all quadrants (12 values averaged) were identified as NFL Overall. Retinal function was assessed by pattern electroretinogram (PERG) recordings using high-contrast (80%) checkerboard stimuli subtending 15 min of the visual arc and reversed at the rate of two reversals/s.
RESULTS: In AD eyes, there was a significant (P<0.01) reduction in NFL thickness in each quadrant and in the NFL Overall evaluation compared with the values observed in control eyes. PERGs showed a significant (P<0.01) delay in N35, P50 and N95 implicit times, and reduction in N35-P50 and P50-N95 amplitudes. NFL Overall values were significantly correlated (P<0.01) to the PERG P50 and N95 implicit times and P50-N95 amplitude. No correlations (P>0.01) between NFL values and other PERG parameters (N35 implicit time, N35-P50 amplitude) were found.
CONCLUSIONS: Our results suggest that in AD patients, there is a reduction of NFL thickness evaluated in vivo by OCT and this morphological abnormality is related to a retinal dysfunction as revealed by abnormal PERG responses.

Entities:  

Mesh:

Year:  2001        PMID: 11595144     DOI: 10.1016/s1388-2457(01)00620-4

Source DB:  PubMed          Journal:  Clin Neurophysiol        ISSN: 1388-2457            Impact factor:   3.708


  127 in total

1.  Cerebrospinal fluid dynamics in the human cranial subarachnoid space: an overlooked mediator of cerebral disease. II. In vitro arachnoid outflow model.

Authors:  David W Holman; Vartan Kurtcuoglu; Deborah M Grzybowski
Journal:  J R Soc Interface       Date:  2010-03-24       Impact factor: 4.118

2.  Optical coherence tomography as a potential readout in clinical trials.

Authors:  Benjamin M Greenberg; Elliot Frohman
Journal:  Ther Adv Neurol Disord       Date:  2010-05       Impact factor: 6.570

3.  Optical coherence tomography assessed retinal nerve fiber layer thickness in patients with Alzheimer's disease: a meta-analysis.

Authors:  Xue-Fei He; Yi-Ting Liu; Cheng Peng; Fan Zhang; Shi Zhuang; Jin-Song Zhang
Journal:  Int J Ophthalmol       Date:  2012-06-18       Impact factor: 1.779

Review 4.  Retinal vascular image analysis as a potential screening tool for cerebrovascular disease: a rationale based on homology between cerebral and retinal microvasculatures.

Authors:  Niall Patton; Tariq Aslam; Thomas Macgillivray; Alison Pattie; Ian J Deary; Baljean Dhillon
Journal:  J Anat       Date:  2005-04       Impact factor: 2.610

Review 5.  Neuroprotection in glaucoma: drug-based approaches.

Authors:  William Cheung; Li Guo; M Francesca Cordeiro
Journal:  Optom Vis Sci       Date:  2008-06       Impact factor: 1.973

6.  Beta-amyloid deposition and functional impairment in the retina of the APPswe/PS1DeltaE9 transgenic mouse model of Alzheimer's disease.

Authors:  Sylvia E Perez; Stephen Lumayag; Beatrix Kovacs; Elliott J Mufson; Shunbin Xu
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-09-12       Impact factor: 4.799

7.  Decreased retinal sensitivity and loss of retinal nerve fibers in multiple system atrophy.

Authors:  M Dominik Fischer; Matthis Synofzik; Christoph Kernstock; Janko Dietzsch; Robert Heidlauf; Julia Schicks; Karin Srulijes; Sarah Wiethoff; Oliver Menn; Daniela Berg; Ludger Schöls; Ulrich Schiefer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-08-10       Impact factor: 3.117

Review 8.  Protein misfolding and retinal degeneration.

Authors:  Radouil Tzekov; Linda Stein; Shalesh Kaushal
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-11-01       Impact factor: 10.005

9.  Amyloid-beta deposits lead to retinal degeneration in a mouse model of Alzheimer disease.

Authors:  Allison Ning; Jing Cui; Eleanor To; Karen Hsiao Ashe; Joanne Matsubara
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-06-19       Impact factor: 4.799

10.  Amyloid-peptide vaccinations reduce {beta}-amyloid plaques but exacerbate vascular deposition and inflammation in the retina of Alzheimer's transgenic mice.

Authors:  Bingqian Liu; Suhail Rasool; Zhikuan Yang; Charles G Glabe; Steven S Schreiber; Jian Ge; Zhiqun Tan
Journal:  Am J Pathol       Date:  2009-10-15       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.